Circular RNA midline-1 (circMID1) promotes proliferation, migration, invasion and glycolysis in prostate cancer

References

• Grozescu T, Popa F. Prostate cancer between prognosis and adequate/proper therapy. J Med Life. 2017;10(1):5–12.
   PubMedGoogle Scholar
• Rebbeck TR. Prostate cancer genetics: variation by race, ethnicity, and geography. Semin Radiat Oncol. 2017;27(1):3–10.
   PubMed Web of Science ®Google Scholar
• Chang AJ, Autio KA, Roach M, et al. High-risk prostate cancer-classification and therapy. Nat Rev Clin Oncol. 2014;11(6):308–323.
   PubMed Web of Science ®Google Scholar
• Wang G, Zhao D, Spring DJ, et al. Genetics and biology of prostate cancer. Genes Dev. 2018;32(17–18):1105–1140.
   PubMed Web of Science ®Google Scholar
• Komura K, Sweeney CJ, Inamoto T, et al. Current treatment strategies for advanced prostate cancer. Int J Urol. 2018;25(3):220–231.
   PubMed Web of Science ®Google Scholar
• Holm HV, Dahl AA, Klepp OH, et al. Modern treatment of metastatic prostate cancer. Tidsskr Nor Laegeforen. 2017;137(11):803–805.
   PubMed Web of Science ®Google Scholar
• Chen -L-L, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381–388.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691.
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388.
   PubMed Web of Science ®Google Scholar
• Su Q, Lv X. Revealing new landscape of cardiovascular disease through circular RNA-miRNA-mRNA axis. Genomics. 2020;112(2):1680–1685.
   PubMed Web of Science ®Google Scholar
• Zhang HD, Jiang L-H, Sun D-W, et al. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2018;25(1):1–7.
   PubMed Web of Science ®Google Scholar
• Lei B, Tian Z, Fan W, et al. Circular RNA: a novel biomarker and therapeutic target for human cancers. Int J Med Sci. 2019;16(2):292–301.
   PubMed Web of Science ®Google Scholar
• Shen Z, Zhou L, Zhang C, et al. Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel. Cancer Lett. 2020;468:88–101.
   PubMed Web of Science ®Google Scholar
• Li T, Sun X, Chen L. Exosome circ_0044516 promotes prostate cancer cell proliferation and metastasis as a potential biomarker. J Cell Biochem. 2020;121(3):2118–2126.
   PubMed Web of Science ®Google Scholar
• Shi J, Liu C, Chen C, et al. Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis. Aging (Albany NY). 2020;12(13):13255–13280.
   PubMedGoogle Scholar
• Han Y, Wen X, Li X, et al. Circular RNA hsa_circ_0075542 acts as a sponge for microRNA-1197 to suppress malignant characteristics and promote apoptosis in prostate cancer cells. Bioengineered. 2021;12(1):5620–5631.
   PubMed Web of Science ®Google Scholar
• Luo GC, Chen L, Fang J, et al. Hsa_circ_0030586 promotes epithelial-mesenchymal transition in prostate cancer via PI3K-AKT signaling. Bioengineered. 2021;12(2):11089–11107.
   PubMed Web of Science ®Google Scholar
• Li J, Choi E, Yu H, et al. Structural basis of the activation of type 1 insulin-like growth factor receptor. Nat Commun. 2019;10(1):4567.
   PubMed Web of Science ®Google Scholar
• Tognon CE, Sorensen PH. Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy. Expert Opin Ther Targets. 2012;16(1):33–48.
   PubMed Web of Science ®Google Scholar
• Xiong W, Huang C, Deng H, et al. Oncogenic non-coding RNA NEAT1 promotes the prostate cancer cell growth through the SRC3/IGF1R/AKT pathway. Int J Biochem Cell Biol. 2018;94:125–132.
   PubMed Web of Science ®Google Scholar
• Yue Y, Liu J, He C. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev. 2015;29(13):1343–1355.
   PubMed Web of Science ®Google Scholar
• He JJ, Li Z, Rong ZX, et al. m(6)A Reader YTHDC2 promotes radiotherapy resistance of nasopharyngeal carcinoma via activating IGF1R/AKT/S6 signaling axis. Front Oncol. 2020;10:1166.
   PubMed Web of Science ®Google Scholar
• Wu Q, Xie X, Huang Y, et al. N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer. J Cancer. 2021;12(3):682–692.
   PubMed Web of Science ®Google Scholar
• Gao C, Wen Y, Jiang F, et al. Circular RNA circ_0008274 upregulates granulin to promote the progression of hepatocellular carcinoma via sponging microRNA −140-3p. Bioengineered. 2021;12(1):1890–1901.
   PubMed Web of Science ®Google Scholar
• Ji F, Du R, Chen T, et al. Circular RNA circSLC26A4 accelerates cervical cancer progression via miR-1287-5p/HOXA7 Axis. Mol Ther Nucleic Acids. 2020;19:413–420.
   PubMedGoogle Scholar
• Li J, Fan R, Xiao H. Circ_ZFR contributes to the paclitaxel resistance and progression of non-small cell lung cancer by upregulating KPNA4 through sponging miR-195-5p. Cancer Cell Int. 2021;21(1):15.
   PubMed Web of Science ®Google Scholar
• Kong Z, Wan X, Lu Y, et al. Circular RNA circFOXO3 promotes prostate cancer progression through sponging miR-29a-3p. J Cell Mol Med. 2020;24(1):799–813.
   PubMed Web of Science ®Google Scholar
• Xiang Z, Xu C, Wu G, et al. CircRNA-UCK2 Increased TET1 inhibits proliferation and invasion of prostate cancer cells via sponge MiRNA-767-5p. Open Med (Wars). 2019;14(1):833–842.
   PubMedGoogle Scholar
• Du P, Liu F, Liu Y, et al. Linc00210 enhances the malignancy of thyroid cancer cells by modulating miR-195-5p/IGF1R/Akt axis. J Cell Physiol. 2020;235(2):1001–1012.
   PubMed Web of Science ®Google Scholar
• Li XX, Huang L-Y, Peng -J-J, et al. Klotho suppresses growth and invasion of colon cancer cells through inhibition of IGF1R-mediated PI3K/AKT pathway. Int J Oncol. 2014;45(2):611–618.
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng J-N, Wang E-H, et al. The m6A reader protein YTHDC2 is a potential biomarker and associated with immune infiltration in head and neck squamous cell carcinoma. PeerJ. 2020;8:e10385.
   PubMed Web of Science ®Google Scholar
• Zhuang J, Lin C, Ye J. m(6) A RNA methylation regulators contribute to malignant progression in rectal cancer. J Cell Physiol. 2020;235(9):6300–6306.
   PubMed Web of Science ®Google Scholar
• Tanabe A, Tanikawa K, Tsunetomi M, et al. RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1alpha mRNA is translated. Cancer Lett. 2016;376(1):34–42.
   PubMed Web of Science ®Google Scholar
• Jin Z, Jia B, Tan L, et al. miR-330-3p suppresses liver cancer cell migration by targeting MAP2K1. Oncol Lett. 2019;18(1):314–320.
   PubMed Web of Science ®Google Scholar
• Huang Y, Sun H, Ma X, et al. HLA-F-AS1/miR-330-3p/PFN1 axis promotes colorectal cancer progression. Life Sci. 2020;254:117180.
   PubMed Web of Science ®Google Scholar
• Guan A, Wang H, Li X, et al. MiR-330-3p inhibits gastric cancer progression through targeting MSI1. Am J Transl Res. 2016;8(11):4802–4811.
   PubMed Web of Science ®Google Scholar
• Wu YP, Lin X-D, Chen S-H, et al. Identification of prostate cancer-related circular RNA through bioinformatics analysis. Front Genet. 2020;11:892.
   PubMed Web of Science ®Google Scholar
• Li Q, Wang W, Zhang M, et al. Circular RNA circ-0016068 promotes the growth, migration, and invasion of prostate cancer cells by regulating the miR-330-3p/BMI-1 axis as a competing endogenous RNA. Front Cell Dev Biol. 2020;8:827.
   PubMed Web of Science ®Google Scholar